Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I) is a PHASE1 clinical asset sponsored by University of Utah in Spinal Muscular Atrophy Type I. SEO and diligence focus: Valproic Acid and Levocarnitine, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.